Last reviewed · How we verify
PF-08046876 (pf-08046876)
At a glance
| Generic name | pf-08046876 |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |